| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 60, 967-971, Copyright © 1985 by Endocrine Society
ARTICLES |
S Iida, M Gomi, K Moriwaki, Y Itoh, K Hirobe, Y Matsuzawa, S Katagiri, T Yonezawa and S Tarui
This report describes studies of a man suspected of having primary cortisol resistance. This conclusion is based on his high plasma cortisol levels and high 24-h urinary 17-hydroxycorticosteroid and cortisol excretion, plus the fact that he had no manifestations of Cushing's syndrome. Among family members tested, his mother also had hypercortisolemia. Both mother and son had high levels of unbound plasma cortisol, but their plasma ACTH concentrations were within the normal range. Both were partially resistant to dexamethasone adrenal suppression, and both had mild hypertension without hypokalemia. To study this apparent end-organ resistance to cortisol, we examined the glucocorticoid receptors in peripheral mononuclear cells. Using whole cell assays, glucocorticoid receptors in both patients were found to have reduced total binding capacity. We conclude that these two patients, members of the same family, have primary cortisol resistance accompanied by a reduced number of glucocorticoid receptors.
This article has been cited by other articles:
![]() |
H. Russcher, P. Smit, E. F. C. van Rossum, E. L. T. van den Akker, A. O. Brinkmann, L. J. M. de Heide, F. H. de Jong, J. W. Koper, and S. W. J. Lamberts Strategies for the Characterization of Disorders in Cortisol Sensitivity J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 694 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. KINO, A. VOTTERO, E. CHARMANDARI, and G. P. CHROUSOS Familial/Sporadic Glucocorticoid Resistance Syndrome and Hypertension Ann. N.Y. Acad. Sci., September 1, 2002; 970(1): 101 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Whorwood, S. J. Donovan, D. Flanagan, D. I.W. Phillips, and C. D. Byrne Increased Glucocorticoid Receptor Expression in Human Skeletal Muscle Cells May Contribute to the Pathogenesis of the Metabolic Syndrome Diabetes, April 1, 2002; 51(4): 1066 - 1075. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kino, R. H. Stauber, J. H. Resau, G. N. Pavlakis, and G. P. Chrousos Pathologic Human GR Mutant Has a Transdominant Negative Effect on the Wild-Type GR by Inhibiting Its Translocation into the Nucleus: Importance of the Ligand-Binding Domain for Intracellular GR Trafficking J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5600 - 5608. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. T. M. Huizenga, P. de Lange, J. W. Koper, W. W. de Herder, R. Abs, J. H. L. M. v. Kasteren, F. H. de Jong, and S. W. J. Lamberts Five Patients with Biochemical and/or Clinical Generalized Glucocorticoid Resistance without Alterations in the Glucocorticoid Receptor Gene J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2076 - 2081. [Abstract] [Full Text] |
||||
![]() |
New Resistance to Several Steroids in Two Sisters J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4454 - 4464. [Abstract] [Full Text] |
||||
![]() |
S. D. Hearing, M. Norman, C. Smyth, C. Foy, and C. M. Dayan Wide Variation in Lymphocyte Steroid Sensitivity Among Healthy Human Volunteers J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4149 - 4154. [Abstract] [Full Text] |
||||
![]() |
N. B. Hastings, M. Orchinik, M. V. Aubourg, and B. S. McEwen Pharmacological Characterization of Central and Peripheral Type I and Type II Adrenal Steroid Receptors in the Prairie Vole, a Glucocorticoid-Resistant Rodent Endocrinology, October 1, 1999; 140(10): 4459 - 4469. [Abstract] [Full Text] |
||||
![]() |
S D Hearing, M Norman, C S J Probert, N Haslam, and C M Dayan Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes Gut, September 1, 1999; 45(3): 382 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Ramos, W. J. Meilandt, E. C. Wang, and G. L. Firestone Dysfunctional glucocorticoid receptor with a single point mutation ablates the CCAAT/enhancer binding protein-dependent growth suppression response in a steroid-resistant rat hepatoma cell variant FASEB J, January 1, 1999; 13(1): 169 - 180. [Abstract] [Full Text] |
||||
![]() |
M. Hughes, P. Malloy, D. Kieback, R. Kesterson, J. Pike, D Feldman, and B. O'Malley Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets Science, December 23, 1988; 242(4886): 1702 - 1705. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |